Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-03

Clinical Trial Update: Erythromycin in Parkinson's Disease [NA]

View source ↗

Summary

A clinical trial evaluating erythromycin in Parkinson's disease has completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERYTHROMYCIN (ERYTHROMYCIN)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Parkinson's Disease, Levodopa | NA | Status: COMPLETED | Results posted: 2017-02-03